Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)425-426
Number of pages2
JournalJournal of Urology
Volume182
Issue number2
DOIs
StatePublished - Aug 2009

Fingerprint

Kidney Neoplasms
Renal Cell Carcinoma
Antineoplastic Agents
Interleukin-2
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma. / Gardner, Thomas; Logan, Theodore.

In: Journal of Urology, Vol. 182, No. 2, 08.2009, p. 425-426.

Research output: Contribution to journalArticle

@article{8535f1f53bb249ce94623da4631d02da,
title = "Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma",
author = "Thomas Gardner and Theodore Logan",
year = "2009",
month = "8",
doi = "10.1016/j.juro.2009.05.073",
language = "English",
volume = "182",
pages = "425--426",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma

AU - Gardner, Thomas

AU - Logan, Theodore

PY - 2009/8

Y1 - 2009/8

UR - http://www.scopus.com/inward/record.url?scp=67649794776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649794776&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2009.05.073

DO - 10.1016/j.juro.2009.05.073

M3 - Article

C2 - 19524946

AN - SCOPUS:67649794776

VL - 182

SP - 425

EP - 426

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -